Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of SEC61A1 mRNA | increases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SEC61A1 mRNA | affects expression | 16483693
|
D001280 |
Atrazine |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of SEC61A1 mRNA | affects cotreatment|decreases expression | 15654877
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SEC61A1 mRNA | affects cotreatment|affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SEC61A1 mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SEC61A1 mRNA | affects cotreatment|affects expression | 17602206
|
D004237 |
Diuron |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of SEC61A1 mRNA | affects cotreatment|decreases expression | 15654877
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SEC61A1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of SEC61A1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC61A1 mRNA | affects cotreatment|increases expression | 17942748
|
D019833 |
Genistein |
Genistein results in decreased expression of SEC61A1 mRNA | decreases expression | 16705744
|
C028904 |
isoproturon |
[Atrazine co-treated with Diuron co-treated with isoproturon] results in decreased expression of SEC61A1 mRNA | affects cotreatment|decreases expression | 15654877
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of SEC61A1 mRNA | decreases expression | 16807920
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of SEC61A1 mRNA | affects expression | 17555576
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of SEC61A1 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC61A1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SEC61A1 mRNA | increases expression | 17942748
|
C032910 |
triadimefon |
triadimefon results in decreased expression of SEC61A1 mRNA | decreases expression | 16730040
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.38 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
4.38 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.72 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.72 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.23 | 16434500 17620307 18056438 19061943 17162532 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.23 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.27 | 11874814 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.07 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.95 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
1.95 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.95 | 19200415 16818667 19410462 19142967 19487384 19011961 17261762 18855134 16873071 20135344 15668708 19289846 17440819 18815881 19103187 15565566 21138602 18351453 19288272 17893378 18425577 18629630 20005174 19155303 18984771 19059307 17049068 17242785 21152245 19066611 19084267 19189210 20859285 16202921 20390343 18821012 16273361 19244106 19189212 20065188 18997820 19115204 11161223 20544844 19221464 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.95 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.55 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
6.62 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.62 | 16569478 16807293 18665156 18506893 20214788 17162532 20727157 17173139 17055752 17428255 19919837 16288022 19208518 19539802 16878318 16830150 10737359 20512989 18056438 20935162 20432363 19822196 19418558 21159647 18393292 20007298 16681979 19383236 18788625 17138121 18971187 20524982 20514400 19701751 16935385 16779866 17761372 16698587 3084413 18978308 16328049 19171122 10672840 19107877 16502159 20101231 18691550 19519916 3581430 19394651 19052882 19335982 11831363 20084675 18785209 16540662 18494052 17978847 18210153 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
6.62 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.62 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.69 | 7296757 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.64 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.32 | 16332659 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.27 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.27 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.27 | 17174075 2727394 21159647 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.41 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.51 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.51 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.51 | 16105132 17333356 16919318 11677210 17110522 17681005 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.19 | 12621046 15340226 16354765 15668235 8697196 |
MESH:D002972 |
Cleft Palate |
|
triadimefon |
6.19 | 16781842 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.29 | 17182828 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 16759393 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
triadimefon |
2.84 | 15834900 16875885 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.40 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 18759878 11906362 8156756 11298694 2524372 8970840 14531868 12868966 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
7.15 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
7.15 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.15 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.50 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.22 | 7440962 8291058 16192314 9653073 9022650 6679447 18692083 1440618 9328219 18289764 18648102 11289319 6482804 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.22 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.22 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.07 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.07 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.64 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.59 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.59 | 19155303 20544844 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.18 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.11 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
19.01 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
19.01 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.01 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
19.01 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.25 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.23 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.28 | 16598420 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.96 | 15340226 12621046 16120746 |
MESH:D006529 |
Hepatomegaly |
|
triadimefon |
8.96 | 17178688 17178689 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.81 | 17440010 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 18606429 8697196 16354765 15340226 16959395 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
6.97 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.97 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.35 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.35 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.35 | 12878042 12200463 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.42 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
triadimefon |
10.42 | 15992940 15834900 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.35 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.51 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.51 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.51 | 18625569 |
MESH:D007938 |
Leukemia |
|
Genistein |
3.04 | 17468513 18980019 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.17 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.84 | 19638242 18407596 20032147 18522880 18665156 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.50 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.50 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.50 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.50 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
triadimefon |
4.50 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
14.38 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
14.38 | 19090486 15885732 19812893 19850985 18648771 19833225 15175105 19255062 19254457 9163691 2422723 19256749 21071580 19073162 19294768 20137499 2862719 19996281 18977376 12112319 20452335 18754104 18978307 16942905 20118626 19499222 18644402 10737359 20501860 20492335 20101389 21167192 19551842 19426721 19642983 19690152 20405173 21278145 19638242 12771043 19427195 20583210 21047994 20434301 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.38 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.38 | 16984957 |
MESH:D008113 |
Liver Neoplasms |
|
triadimefon |
14.38 | 19028983 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.30 | 1399818 3712494 6587162 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.30 | 17854601 19009564 19126423 17174075 19519916 16267830 18253720 2563599 18282651 18775883 21159647 9362446 16842330 18079962 18308698 19004024 18093689 19539802 17942915 18544905 18164116 3124819 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.30 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
triadimefon |
14.30 | 17178689 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.38 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.38 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.38 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.81 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
6.17 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.17 | 19196723 11731420 19196722 16827153 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.61 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.88 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.23 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.54 | 1916698 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.87 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.68 | 17141266 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.52 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
9.52 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.52 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.06 | 19189210 19196722 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
9.73 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.73 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.93 | 6679447 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.36 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.18 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.45 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.27 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.12 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
2.61 | 19005980 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.43 | 16540662 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.28 | 17218051 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.03 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.03 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.24 | 11896295 11399792 11222880 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.31 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.31 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.56 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.05 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.77 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.77 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.09 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.22 | 1399818 6587162 6582329 7505956 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
12.22 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
triadimefon |
12.22 | 17178689 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.07 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.07 | 8653321 16712894 17572228 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |